Somatostatin receptor scintigraphy with In-111-octreotide in pulmonary carcinoid tumours correlated with pathological and (18)FDG PET/CT findings

Kuyumcu S., Adalet I., Sanli Y., Turkmen C., Ozkan Z. G., Yilmazbayhan D.

ANNALS OF NUCLEAR MEDICINE, vol.26, no.9, pp.689-697, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 26 Issue: 9
  • Publication Date: 2012
  • Doi Number: 10.1007/s12149-012-0628-x
  • Journal Name: ANNALS OF NUCLEAR MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.689-697
  • Keywords: Pulmonary carcinoid, Somatostatin receptor scintigraphy, FDG PET, Ki-67, POSITRON-EMISSION-TOMOGRAPHY, NEUROENDOCRINE TUMORS, LUNG, MANAGEMENT, SURVIVAL
  • Istanbul University Affiliated: Yes

Abstract

Pulmonary carcinoid (PC) tumors are rare neoplasms of the lung with good prognosis but diagnosis may be demanding since there is no exclusive modality alone to clearly differentiate a PC tumor. The purpose of this study is to establish the diagnostic features of somatostatin receptor scintigraphy (SRS), comparatively (where available) with (18)FDG PET/CT (PET/CT) correlated with histopathologic findings.